Logo

Effect of Zinc Supplementation on Inflammatory Markers in Women with Polycystic Ovary Syndrome.

Author(s):
 F Pourteymour Fard Tabrizi F Pourteymour Fard Tabrizi1,*, B Alipoor B Alipoor 2, AR Ostadrahimi AR Ostadrahimi 3, M Mehrzad Sadagiani M Mehrzad Sadagiani 4
1Masters Student
2Assistant professor, Section of Nutrition. Faculty of Health and Nutrition,
3Associate Professor. Section of Nutrition, Nutrition Research Center
4Assistant Professor. Section of Infertility, Department of Obstetrics and Gynecology, Faculty of Medicine, Tabriz University of Medical Sciences, Tabriz, Iran.


Shiraz E-Medical Journal:Vol. 12, issue 1; 30-38
Published online:Jan 01, 2011
Article type:Research Article
Received:May 24, 2010
Accepted:Sep 11, 2010
How to Cite: F Pourteymour Fard TabriziB Alipoor AR Ostadrahimi M Mehrzad Sadagiani Effect of Zinc Supplementation on Inflammatory Markers in Women with Polycystic Ovary Syndrome..Shiraz E-Med J.12(1):30-38.

Abstract

Abstract:

Background: Polycystic ovary syndrome, as a low-grade chronic inflammatory state, may stimulate the immune response, increasing inflammatory factors such as C-reactive pro-tein (CRP) and Interleukin 6 (IL-6) on one hand and zinc, another effective anti-inflammatory agent, on the other. The aim of this study is to evaluate the effect of zinc on inflammatory markers in women with polycystic ovary syndrome. Patients and Methods: In a randomized, double-blind, and placebo controlled clinical trial, sixty patients with polycystic ovary syndrome were randomly divided into two groups, each group received one of the following daily supplement for eight weeks; group Zn: 50 mg elemental zinc (n = 30), and group P: Placebo (n =30). Fasting serum zinc levels, inflammatory markers, systolic-and diastolic blood pressure, anthropometric indices, and nutritional intake were measured at the baseline and the end of 8th week. Results: Results indicate that after eight weeks of supplementation, mean value of nutri-tional intake, anthropometric indices, and systolic-and diastolic blood pressure did not change significantly in the two groups. Zinc supplementation had significant effects in increasing serum Zn (p < 0.05) and in decreasing serum hs-CRP and IL-6 levels (p < 0.05). There were no significant changes in the levels of these parameters in the placebo group. Conclusions: The findings of the present study indicate that zinc supplementation may be considered as an inexpensive adjunct to treatments in patients with polycystic ovary syndrome in the hope of reducing cardiovascular disease risk factors, particularly inflam-mation.

Full Text

Full text is available in PDF

comments

Leave a comment here

Share on
Metrics

Purchasing Reprints

  • Copyright Clearance Center (CCC) handles bulk orders for article reprints for Brieflands. To place an order for reprints, please click here (   https://www.copyright.com/landing/reprintsinquiryform/ ). Clicking this link will bring you to a CCC request form where you can provide the details of your order. Once complete, please click the ‘Submit Request’ button and CCC’s Reprints Services team will generate a quote for your review.
Search Relations

Author(s):

Related Articles